Evidence map›Paper›PMID 39507014›Full record

ArticleDigital health

Exploring the feasibility, acceptability, usability and safety of a digitally supported self-management intervention for uncontrolled asthma: A pre-post pilot study in secondary care.

Anne Zijp, Anke Versluis, Laura Joosse, Taco Kind, Tess Mj Rouveroy van Nieuwaal, Chantal Wassink-Bergman, Ilonka Hpaa van Veen, Els Jm Weersink, Niels H Chavannes, Jiska J Aardoom

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anne ZijpDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.ORCID https://orcid.org/0000-0002-1967-3059
Anke VersluisDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Laura JoosseDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Taco KindSentoMed BV, The Hague, Netherlands.
Tess Mj Rouveroy van NieuwaalDepartment of Pulmonary Medicine, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, Netherlands.
Chantal Wassink-BergmanDepartment of Pulmonary Medicine, Medical Spectrum Twente, Enschede, Netherlands.
Ilonka Hpaa van VeenDepartment of Pulmonary Medicine, Medical Spectrum Twente, Enschede, Netherlands.
Els Jm WeersinkDepartment of Pulmonary Medicine, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, Netherlands.
Niels H ChavannesDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
Jiska J AardoomDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Asthma control is often suboptimal, which is associated with incorrect medication use and poor asthma management by patients. Astmakompas, a digital self-management intervention, comprises a mobile app for patients, a web portal for healthcare professionals (HCP), and a wireless spirometer. Together, these components are intended to facilitate symptom monitoring, patient-HCP communication and assist in asthma-related self-management. Objective: The pilot study primarily aims to assess the feasibility, acceptability, usability and safety of Astmakompas from patient and HCP perspectives, and secondarily to explore potential effects on asthma control, medication use, Quality of Life, self-efficacy and (in)direct costs. Methods: A mixed-method, multi-center, pre-post study design was conducted in two Dutch hospitals, involving patients with uncontrolled asthma and four HCPs. Primary outcomes were assessed post-intervention using questionnaires and in-depth interviews. Secondary outcomes were assessed at baseline and post-intervention using questionnaires, and post-intervention using in-depth interviews. Results: In general, the data show that Astmakompas was considered feasible, acceptable, usable and safe by both patients ( Conclusion: Astmakompas shows promise for further implementation and research. Future randomized studies with longer evaluation periods are crucial to assess the tool's impact on asthma outcomes and workload. It is important that HCPs guide and tailor interventions to meet the patient's individual needs and circumstances.

Indexed as

Asthmaasthma controlasthma self-managementdigital supported interventioneHealth

Identifiers

PMID39507014
PMCPMC11539187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.